Some aspects of the mechanism of action of various stimulant amphetamine analogues.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009411:Nerve Endings / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D009435:Synaptic Transmission; D014363:Tryptamines / Q000378:metabolism
D000928:Antidepressive Agents; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D010880:Piperidines; D014363:Tryptamines; D012110:Reserpine; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine